2.64 USD
↗ 0.20 (7.99%)LIVE (AS OF 09:58 AM EDT)
Nautilus Biotechnolgy, Inc. Common Stock
NAUTNASDAQ • USD
Market: OPEN
Nautilus Biotechnolgy, Inc. Common Stock (NAUT) trades at $2.64 per share. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Key drivers include a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. NAUT is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Oct 26, 2026.
Open?$2.34
High?$2.74
Low?$2.25
Prev. Close?$2.44
Volume?3.6M
Avg. Volume?8.8M
VWAP?$2.56
Rel. Volume?0.41x
Bid / Ask
Bid?$2.63 × 1.2K
Ask?$2.66 × 400
Spread?$0.03
Midpoint?$2.65
Valuation & Ratios
Market Cap?310.5M
Shares Out?127.3M
Float?54.0M
Float %?42.4%
P/E Ratio?N/A
P/B Ratio?2.37
EPS?-$0.44
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
Themes
Employees
130
Market Cap
310.5M
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Website
Listed
2021-06-10
Address
2701 EASTLAKE AVE EAST
SEATTLE, WA 98102
Phone: 206-333-2001
SEATTLE, WA 98102
Phone: 206-333-2001
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?34
Momentum?50
Short Sent.?53
Piotroski F-Score?0/9Weak
Altman Z-Score?1.96Grey
Confidence?59%Low
Short InterestHigh
Short % of Float?10.41%High
Short Interest?5.6M
Days to Cover?1.0
Free Float54.0M
Avg Daily Volume12.6M
Settlement Date2026-10-15
Financial Health
Current Ratio?10.14Strong
Quick Ratio?10.14Strong
Cash Ratio?1.52Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?2.37CHEAP▾
Peers100
S&P67
P/S?1,634.22HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-4.9CHEAP▾
S&P97
EV/Sales?1,564.93HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-43.1%WEAK▾
S&P3
ROA?-34.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-51861000
Enterprise Value?$297.3M
Fundamentals ratios updated end of day